In findings from a phase 2a trial that were presented at the American Diabetes Association Scientific Sessions and simultaneously published in The Lancet , 71% of adults receiving coadministered cagrilintide and semaglutide 2.4 mg, dubbed CagriSema (Novo Nordisk), lost at least 10% of their body weight, and 89% of adults achieved an HbA1c of less than 7% with the combination therapy
10.1007/s00204-021-03211-z 8 AkakpoJ
doi:10.3389/fnins.2019.00444 Jeng KC, et al
For general mast cell stabilization, KPV does not distinguish between different allergen triggers, so it should help reduce reactivity regardless of the specific allergen
With proven client success stories backing up their methods, there's reassurance in the process being offered here
Glutathione is the mother of all antioxidants that helps fight free radicals, while effectively suppressing melanin of darkened areas